1. Interleukin-31 promotes pathogenic mechanisms underlying skin and lung fibrosis in scleroderma. (4th May 2020) Authors: Yaseen, Bodoor; Lopez, Henry; Taki, Zeinab; Zafar, Sara; Rosario, Henrique; Abdi, Bahja Ahmed; Vigneswaran, Shivanee; Xing, Fiona; Arumalla, Nikita; Black, Simon; Ahmad, Sara; Kumar, Kimti; Gul, Rabia; Scolamiero, Laura; Morris, Sian; Bowman, Alex; Stainer, Anna; Rice, Alexandra; Stock, Carmel; R... Journal: Rheumatology Issue: Volume 59:Number 9(2020) Page Start: 2625 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0182 SYNTHETIC PEPTIDES TARGETING CD206 INHIBIT PATHOGENIC MACROPHAGES IN SYSTEMIC SCLEROSIS. (June 2019) Authors: Lopez, Henry; Kumar, Kimti; Martin, George; Jaynes, Jesse; Stanway, James; Abdi, Bahja Ahmed; Arumalla, Nikita; Karrar, Sarah; Morris, Sian; Denton, Christopher; Abraham, David; Shiwen, Xu; Stratton, Richard Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗